Glucosamine sulfate use in osteoarthritis

American Journal of Health-System Pharmacy

Volumn 56, Issue 3, 1999, Pages 267-269

  Runkel, David R ^a,b   Cupp, Melanik Johns ^b  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; COLLAGEN TYPE 2; COLLAGENASE; CORTICOSTEROID; CYTOKINE; DIACETYLRHEIN; GLUCOSAMINE; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; IBUPROFEN; INTERLEUKIN 1; METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN; PROTEIN; PROTEOGLYCAN; STROMELYSIN; WATER;

EDEMA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEG PAIN; NOTE; NUTRIENT; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL;

EID: 0033083922     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.3.267     Document Type: Note

References (20)

1. Eisenberg DM, Kessler RC, Foster C et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993; 328:246-52.
2. Theodosakis J, Adderly B, Fox B. The arthritis cure. New York: St. Martin's; 1997.
3. McCarty MF. The neglect of glucosamine as a treatment of osteoarthritis - a personal perspective. Med Hypotheses. 1994; 42:323-7.
4. Glucosamine for osteoarthritis. Med Lett Drugs Ther. 1997; 39: 91-2.
5. Brandt KD, Slemenda CW. Osteoarthritis. In: Schumacher HR, ed. Primer on rheumatic diseases. 10th ed. Atlanta: Arthritis Foundation; 1993:184-90.
6. Peyron JG. Osteoarthritis. The epidemiologic viewpoint. Clin Orthop. 1986; 213:13-9.
7. March LM. Osteoarthritis. Med J Aust. 1997; 166:98-103.
8. Pinals RS. Mechanisms of joint destruction, pain, and disability in osteoarthritis. Drugs. 1996; 52(suppl 3):14-20.
9. Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacologic therapy in osteoarthritis of the hip. J Rheumatol. 1997; 24:349-57.
10. Reichelt A, Forster KK, Fischer M et al. Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. Arzneimittelforschung. 1994; 44:75-80.
11. Higgins G. Optimistic look for disease modifiers in osteoarthritis. Inpharma. 1993; Jul 17:3-4.
12. Drovanti A, Bignamini AA, Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthritis: a placebo-controlled double-blind investigation. Clin Ther. 1980; 3:260-72.
13. D'Ambrosio E, Casa B, Bompani R et al. Glucosamine sulphate: a controlled clinical investigation in arthrosis. Pharmacotherapeutica. 1981; 2:504-8.
14. Grolle G, D'Este E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin. 1980; 7:104-9.
15. Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthritis. Curr Med Res Opin. 1980; 7:110-4.
16. Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulfate in the management of osteoarthrosis of the knee in outpatients. Curr Med Res Opin. 1982; 8:145-9.
17. Vajaradul Y. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clin Ther. 1981; 3:336-43.
18. Noack W, Fischer M, Forster KK et al. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994; 2:51-9.
19. Muller-Fabbender H, Bach GL, Haase W et al. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage. 1994; 2:61-9.
20. Shankar RR, Zhu JS, Baron AD. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin dependent diabetes mellitus. Metabolism. 1998; 47:573-7.